International Lung Cancer Congress

19 – 22 July 2012

Compare event hotels rates in 9 hotel booking engines

Shorebreak Hotel - a Joie de Vivre — the closest hotel Hotel Shorebreak Hotel - a Joie de Vivre is located 438m from International Lung Cancer Congress. Use map search to look up the nearest hotels to International Lung Cancer Congress venue. Shorebreak Hotel Shorebreak is located 445m from International Lung Cancer Congress. Use map search to look up the nearest hotels to International Lung Cancer Congress venue. Best Western Huntington Beach Inn Hotel Best Western Huntington Beach Inn is located 535m from International Lung Cancer Congress. Use map search to look up the nearest hotels to International Lung Cancer Congress venue. BEST WESTERN HUNTINGTON BEACH Hotel BEST WESTERN HUNTINGTON BEACH is located 536m from International Lung Cancer Congress. Use map search to look up the nearest hotels to International Lung Cancer Congress venue. Best Western Huntington Beach Inn Hotel Best Western Huntington Beach Inn is located 536m from International Lung Cancer Congress. Use map search to look up the nearest hotels to International Lung Cancer Congress venue. All Hotels

One of reasons why people go to United States is participation in the International Lung Cancer Congress trade show. ExpoPromoter offers you to visit International Lung Cancer Congress, which will take place on 2012, July, 19 in , Huntington Beach.

Organizers did their best to make this trade show pleasing and interesting for visitors, and appropriate for participants to be able to present their goods, ideas or services completely and effectively. Visiting International Lung Cancer Congress you get the possibility to learn about current tendencies, meet your future colleagues, partners and clients. Read about the event, find and book a hotel near its venue using ExpoPromoter.

About International Lung Cancer Congress

The Sixth Annual New York Lung Cancer Symposium brings the key data from international oncology conferences to attending physicians. The importance of molecular pathology in diagnosis and treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. The optimization of adjuvant therapy for patients with early-stage NSCLC and chemoradiation therapy for patients with locally advanced NSCLC will be reviewed. Management of patients with specific molecular defects such as EGFR mutations or the EML4-ALK fusion gene will also be discussed. Didactic lectures from lung cancer experts will set the stage for case-based panel discussions and opportunities for participants to interact with faculty. A multidisciplinary tumor board will discuss current advances and issues in locally advanced NSCLC. The symposium will also feature a case discussion session in which fellows can actively participate and thereby enhance their learning experience.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.

Learning Objectives
At the conclusion of this symposium, you should be able to:

Assess molecular profiling of lung cancer based on tumor characteristics
Summarize the optimal approach to adjuvant chemotherapy for patients with early-stage NSCLC
Discuss the efficacy and toxicity of combined modality regimens in locally advanced NSCLC
Analyze approaches to optimize the use of EGFR inhibitors in patients with EGFR mutations
Evaluate clinical data on maintenance therapy with cytotoxic/targeted agents in advanced NSCLC
Assess clinical data on novel agents in development for lung cancer
Assess potential benefits of clinical trials for individual patients with lung cancer